Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 51 - 60 of 102

Selected Filters:
27 October 2022

England PrEP Monitoring & Evaluation Framework, 2022

This report provides an overview of a national framework to monitor and evaluate the delivery of PrEP in England. The framework includes a set of indicators to be published within existing HIV and STI surveillance outputs.

Monitoring & Evaluation

Document
27 October 2022

England HIV/AIDS Action Plan, 2022-25

A plan aimed at building on recent successes, the goal put forth in this document is zero new infections by 2030.

Monitoring & Evaluation

External Link
19 October 2022

From Policy to Practice: Uptake of PrEP among adolescent girls and young women in PEPFAR-supported countries, 2017–2020

This article from the journal AIDS describes the uptake of PrEP amongst adolescent girls and young women in PEPFAR countries.

Monitoring & Evaluation

External Link
17 October 2022

MOSAIC Across the Product Introduction Framework

The MOSAIC PrEP product introduction framework is a structure for organizing what is needed for national and subnational introduction of PrEP products through five major stages, from initial planning to uptake and ongoing monitoring.

Demand Creation/Marketing, Financing & Costing, Monitoring & Evaluation, Service Delivery, Supply Chain Management

Document
14 October 2022

PrEP Initiations by Country, October 2022

AVAC’s quarterly surveys of ongoing oral PrEP demonstration and implementation projects, combined with data collected from manufacturers and government agencies inform this graphic on PrEP initiations around the globe.

Monitoring & Evaluation

Document
11 October 2022

HIV Drug Resistance Monitoring Protocol Template

This template can be used to develop a protocol to monitor HIV drug resistance among seroconversions in users of PrEP.

Monitoring & Evaluation, Testing

Document
4 October 2022

Continued Attendance in a PrEP Program despite Low Adherence and Non-protective Drug Levels among Adolescent Girls and Young Women in Kenya: Results from a prospective cohort study

This article from PLOS Medicine measures adherence to oral PrEP amongst adolescent girls and young women in Kenya in the DREAMS program while exploring reasons behind adherence.

Monitoring & Evaluation

External Link
4 October 2022

Long-Acting Injectable Cabotegravir for HIV Prevention: What do we know and need to know about the risks and consequences of cabotegravir resistance?

This article from The Science of Prevention summarizes what is known about cabotegravir (CAB) pharmacokinetics, activity, and emergence of resistance from in vitro, macaque and clinical studies, and evaluates the risk of resistance from CAB for PrEP with on-time injections and after CAB for PrEP discontinuation.

Monitoring & Evaluation, Research, Testing

External Link
30 August 2022

HIV Prevention Metrics: Lessons to be learned from contraception

This article from the Journal of the International AIDS Society explores the similarities and differences between the fields of HIV prevention and contraception and discusses how contraceptive metrics could be adapted to assessing HIV prevention.

Monitoring & Evaluation

External Link
30 August 2022

How Gender Norms and ‘Good Girl’ Notions Prevent Adolescent Girls and Young Women from Engaging with PrEP: Qualitative insights from Zimbabwe

This article from BMC Women’s Health explores the role of gender norms in shaping adolescent girls and young women’s (AGYW) engagement with PrEP in Zimbabwe.

Monitoring & Evaluation, Research

External Link